Journal of Medicinal Chemistry · 2015 · 44 citations · 17 references
PharmacyMedicinal ChemistryPharmacologyMolecular PharmacologyStructural BiologyStructure-activity RelationshipsG Protein-coupled Receptor SignalingGlucagon-like Peptide-1 Receptor AgonistsLigand BindingPeptide ChemistryPeptide Drug DiscoveryReceptor-ligand InteractionsAgonist ActivityCyclic Peptide HormonesG Protein-coupled Receptor Structure-function RelationshipsGlp-1 Receptor PharmacologyGlucagon Receptor AgonismGlucagon-like Peptide 1 Receptor AgonismHydrophobic PeptidesSmall-molecule Glp-1 Receptor Agonists
Cyclic constraints are incorporated into an 11-residue analogue of the N-terminus of glucagon-like peptide-1 (GLP-1) to investigate effects of structure on agonist activity. Cyclization through linking side chains of residues 2 and 5 or 5 and 9 produced agonists at nM concentrations in a cAMP assay. 2D NMR and CD spectra revealed an N-terminal β-turn and a C-terminal helix that differentially influenced affinity and agonist potency. These structures can inform development of small molecule agonists of the GLP-1 receptor to treat type 2 diabetes.
17
Diabetes and obesity: the twin epidemics
Simon Smyth, Andrew Heron · Nature Medicine · 2006 · 648 citations
The global implications of diabetes and cancer
Yuankai Shi, Frank B. Hu · The Lancet · 2014 · 433 citations
Medicine, Endocrinology, Oncology +12
Structure of the human glucagon class B G-protein-coupled receptor
Fai Siu, Min He, Chris de Graaf et al. · Nature · 2013 · 377 citations · Full text
Tony Scully · Nature · 2012 · 299 citations · Full text